Specifically, curcumin downregulated the p210 BCR‐ABL fusion protein—a hallmark of CML—and suppressed downstream signaling proteins such as MEK‐1 and c‐JUN, effectively impairing leukemic cell survival. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.